Answer
Yes, human fibrinogen concentrate carries a risk of thrombosis in patients with congenital fibrinogen deficiency, particularly with high doses or repeated dosing, and patients should be closely observed for signs or symptoms of thrombosis.
Sources for this answer
- Riastap 1gCSL Behring UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked